Clinical Research in Southampton
Southampton Children's Hospital

A A A Text only | Accessibility | Privacy and cookies

Home
About the Trust
Our services
Patients and visitors
Our hospitals
Education
Research
Working here
Contact us

Browse site A to Z

A
B
C
D
E
F
G
H
I
J
K
L
M
N
O
P
Q
R
S
T
U
V
W
X
Y
Z

Search results

Go To Simple Search

Search Type: Criteria:

You could also try: collapse (38), fall down (135), drop (300), sink (14), slip (31), dip (38), become less (262)

Having an ultrasound-guided tunnelled drain insertion - patient information

Description: This factsheet explains what an ultrasound-guided tunnelled drain insertion is, what the procedure involves and how to prepare for it
Url: /Media/UHS-website-2019/Patientinformation/Scansandx-rays/Having-an-ultrasound-guided-tunnelled-drain-insertion-3302-PIL.pdf

Cabozantinib

Description: Chemotherapy Protocol RENAL CELL CANCER Regimen CABOZANTINIB • Renal Cell – Cabozantinib (60mg-tablets) Indication • Cabozantinib s indicated for the treatment of advanced
Url: /Media/UHS-website-2019/Docs/Chemotherapy-SOPs1/Renal-cell/Cabozantinib.pdf

HSCTMelphalan-Bortezomib IV

Description: Chemotherapy Protocol HAEMATOLOGY – HSCT AUTOGRAFT InP - MELPHALAN and BORTEZOMIB (IV) Please confirm correct protocol with transplant schedule Regimen • HSCT – InP - Melphalan
Url: /Media/UHS-website-2019/Docs/Chemotherapy-SOPs1/Transplant/HSCTMelphalan-Bortezomib-IV.pdf

HSCTMelphalan 200mg/m²

Description: Chemotherapy Protocol HAEMATOLOGY – HSCT AUTOGRAFT MELPHALAN (200mg/m2) Multiple Myeloma This regimen will only be available to prescribe at units which
Url: /Media/UHS-website-2019/Docs/Chemotherapy-SOPs1/Transplant/HSCTMelphalan-200mg-m².pdf

Thyroid Cabozantinib

Description: Chemotherapy Protocol THYROID CANCER Regimen CABOZANTINIB • Thyroid – Cabozantinib (140mg-capsules) Indication • Unresectable, locally advanced or metastatic thyroid cancer where the disease
Url: /Media/UHS-website-2019/Docs/Chemotherapy-SOPs1/Endocrinecancer/Thyroid-Cabozantinib.pdf

Leg amputation - patient information

Description: Information about leg amputation surgery, performed as an absolute last resort for poor blood flow to your leg, or a serious
Url: /Media/UHS-website-2019/Patientinformation/Cardiovascular-and-thoracic/Leg-amputation-1661-PIL.pdf

Tissue removal and amputation of the toe and the foot - patient information

Description: Information about tissue removal when there is a serious infection in the skin and tissue of the toes and foot
Url: /Media/UHS-website-2019/Patientinformation/Cardiovascular-and-thoracic/Tissue-removal-and-amputation-of-the-toe-and-the-foot-1660-PIL.pdf

Recovering from a heart attack - patient information

Description: This booklet has been produced by the cardiac rehabilitation team to help you and your family understand more about your condition
Url: /Media/UHS-website-2019/Patientinformation/Heartandlungs/Recovering-from-a-heart-attack-1363-PIL.pdf

Daratumumab SC Ver1

Description: Chemotherapy Protocol Myeloma Daratumumab Subcutaneous Regimen • Myeloma – Daratumumab (SC) Indication • Daratumumab monotherapy is r
Url: /Media/UHS-website-2019/Docs/Chemotherapy-SOPs1/Myeloma/Daratumumab-SC-Ver1.pdf

DRD Daratumumab-Lenalidomide-Dexamethasone

Description: Chemotherapy Protocol Myeloma DRD Daratumumab-Lenalidomide-Dexamethasone Regimen • Myeloma – DRD Daratumumab-Lenalidomide-Dexamethason
Url: /Media/UHS-website-2019/Docs/Chemotherapy-SOPs1/Myeloma/DRD-Daratumumab-Lenalidomide-Dexamethasone.pdf

11 to 20 of 22

Previous 1 2 3 Next